A Prospective, Multi-centered, Randomized Phase III Study to Compare Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
Latest Information Update: 13 May 2025
At a glance
- Drugs Tislelizumab (Primary) ; Cisplatin; Paclitaxel
- Indications Hypopharyngeal cancer; Laryngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms PRECEDE
Most Recent Events
- 13 May 2025 New trial record